<?xml version="1.0" encoding="UTF-8"?>
<p>Cancer is a multifactorial and multitarget disease treated, at present, mainly employing chemotherapy, radiotherapy, and immunotherapy. However, these therapies carry the appearance of detrimental effects mainly due to MDR. Understanding how the switch between sensitive and resistant states is activated and what factors control it would be key to designing new effective treatment strategies for MDR cancers [
 <xref rid="B3-biomolecules-10-00817" ref-type="bibr">3</xref>]. 
</p>
